Potential approval of pacritinib for the treatment of myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 1:15 3 years ago 293 Далее Скачать
The value of pacritinib in the treatment of MF VJHemOnc – Video Journal of Hematology & HemOnc 1:20 2 years ago 113 Далее Скачать
MOMENTUM & the potential impact of approval of momelotinib in myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 2:20 1 year ago 545 Далее Скачать
Risk-adjusted safety analysis of pacritinib for patients with MF VJHemOnc – Video Journal of Hematology & HemOnc 1:31 2 years ago 262 Далее Скачать
Dr. Mascarenhas on the Potential Role of Pacritinib in MPNs OncLive 1:37 4 years ago 210 Далее Скачать
Pacritinib for patients with MF across the cytopenic spectrum VJHemOnc – Video Journal of Hematology & HemOnc 4:12 1 year ago 290 Далее Скачать
The role of pacritinib in managing thrombocytopenia in patients with myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 0:46 2 years ago 85 Далее Скачать
FDA Approves Pacritinib for Patients with Myelofibrosis&Severe Thrombocytopenia | CTI VONJO medXclusive Learning 4:17 2 years ago 766 Далее Скачать
Pacritinib activity against myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 5:10 4 years ago 794 Далее Скачать
Novel drugs and treatment strategies for myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 3:23 3 years ago 339 Далее Скачать
Safety of full dose pacritinib is comparable to best available therapy for cytopenic myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 1:33 2 years ago 188 Далее Скачать
Novel JAK inhibitor pacritinib proving effective for easing symptoms of myelofibrosis ecancer 4:46 9 years ago 26 Далее Скачать
Safety of full dose pacritinib versus BAT in patients with cytopenic myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 4:07 2 years ago 309 Далее Скачать
Top 10 Facts that Patients with Myeloproliferative Neoplasms Need to Know About Pacritinib (Vonjo) UT Health San Antonio MD Anderson Cancer Center 11:24 2 years ago 1 946 Далее Скачать
Fedratinib Reemerges as FDA-Approved Treatment of Myelofibrosis Targeted Oncology 1:10 5 years ago 387 Далее Скачать
Approved & emerging JAK inhibitors for patients with high-risk MF who are transplant-ineligible VJHemOnc – Video Journal of Hematology & HemOnc 2:09 1 year ago 129 Далее Скачать
Pacritinib versus ruxolitinib in patients with myelofibrosis and thrombocytopenia VJHemOnc – Video Journal of Hematology & HemOnc 1:59 2 years ago 332 Далее Скачать
PERSIST-1: Pacritinib Shakes Up the Current Myelofibrosis Treatment Landscape American Society of Hematology 5:23 9 years ago 461 Далее Скачать
John Mascarenhas, MD, MS: Continuing to Evaluate Pacritinib for Myelofibrosis American Society of Hematology 4:59 8 years ago 660 Далее Скачать
